2794 J. Am. Chem. Soc., Vol. 122, No. 12, 2000
Older and Stryker
product was redissolved in pentane and filtered through a plug of
alumina (5% H2O). After evaporation of pentane the product (0.031 g,
62%) was obtained as an off-white solid and used without further
purification. 1H NMR (400 MHz, CD2Cl2): δ 4.36 (s, 5H, C5H5), 2.41
(s, 3H, CH3), 2.21 (q, J ) 7.1 Hz, 1H, exo-H), 1.94 (s, 6H, CH3), 1.35
(s, 6H, CH3), 1.12 (d, J ) 7.1 Hz, 3H, endo-CH3). 13C{1H} NMR (100
MHz, CD2Cl2): δ 91.9, 91.2, 78.3, 39.9, 37.0, 18.9, 17.6, 17.4, 17.1.
6H, CH3), 1.31 (d, J ) 6.7 Hz, 3H, endo-CH3), -4.81 (d of sept, J )
13.3, 2.6 Hz, 1H, Hag).
Addition of MeOH to 8. Methanol (0.008 mL, 6.5 equiv) was added
via microsyringe to the solution of [(C5H5)Ru(η4-1,2,3,4,5-exo-6-endo-
hexamethylcyclohexa-1,3-diene)]+BF4 (8) prepared above and the
-
reaction monitored spectroscopically. Complete conversion to [(C5H5)-
Ru(η6-C6Me6)]+BF4- (4) was observed within 4 h at room temperature,
accompanied by a trace of decomposition products.
[(C5Me5)Ru(η6-C6Me5H)]+BF4 (6). A procedure similar to that
-
4
5
[(C Me5)Ru(η -1,2,3,4,5-exo-6-endo-hexamethylcyclohexa-1,3-
diene)]+OTf- (9). A solution of (C5Me5)Ru(η5-1,2,3,4,5,6-endo-hexa-
methylcyclohexadienyl) (3, 0.030 g, 0.075 mmol) in anhydrous CD2Cl2
was placed into an NMR tube equipped with a rubber septum. Triflic
acid (0.007 mL, 0.079 mmol) was then added via microsyringe and
the resulting solution analyzed by 1H and 13C{1H} NMR spectroscopy.
1H NMR (400 MHz, CD2Cl2): δ 2.44 (dq, J ) 13.0, 6.6 Hz, 1H, exo-
H), 2.40 (s, 3H, CH3), 1.85 (s, 6H, CH3), 1.77 (s, 15H, C5Me5), 1.44
(d, J ) 2.4 Hz, 6H, CH3), 1.21 (d, J ) 6.6 Hz, 3H, endo-CH3), -5.82
(br d, J ) 13.0 Hz, Hag). 13C{1H} NMR (100 MHz, CD2Cl2): δ 101.9,
99.9, 96.8, 67.1, 42.1, 16.9, 16.0, 14.9, 14.2, 9.7 (triflate carbon not
observed).
described for complex 2 above was followed, except that pentameth-
ylbenzene was used in place of hexamethylbenzene. Thus, a mixture
of [(C5Me5)RuCl]4 (0.300 g, 1.104 mmol/Ru), pentamethylbenzene
(0.840 g, 5.66 mmol), and silver tetrafluoroborate (0.218 g, 1.12 mmol)
in 12 mL of dichloromethane was maintained at a gentle reflux for 5
h. A bright white powder (0.483 g, 93%) was isolated after recrystal-
lization from dichloromethane/diethyl ether. 1H NMR (400 MHz, CD2-
Cl2): δ 5.46 (s, 1H, C6Me5H), 2.10 (s, 6H, C6Me5H), 2.06 (s, 3H,
C6Me5H), 2.03 (s, 6H, C6Me5H), 1.71 (s, 15H, C5Me5). 13C{1H} NMR
(100 MHz, CD2Cl2): δ 99.2, 99.1, 98.7, 93.1, 91.5, 17.9, 14.7, 14.2,
9.4. Anal. Calcd for C21H31RuBF4: C, 53.51%; H, 6.63. Found: C,
53.38; H, 6.52.
Addition of MeOH to 9. Methanol (0.011 mL, 6.0 equiv) was added
via microsyringe to the CD2Cl2 solution of [(C5Me5)Ru(η4-1,2,3,4,5-
exo-6-endo-hexamethylcyclohexa-1,3-diene)]+OTf- (9) prepared above
and the reaction monitored spectroscopically. After 24 h, only 21%
conversion to [(C5Me5)Ru(η6-C6Me6)]+OTf- (2) was observed. The
reaction was complete after about 5 days at room temperature.
[(C5Me5)Ru(η4-1,2,3,4,5-exo-6-exo-hexamethylcyclohexa-1,3-di-
ene)]+OTf- (10). A solution of (C5Me5)Ru(η5-1,2,3,4,5,6-exo-hexa-
methylcyclohexadienyl) (7, 0.015 g, 0.038 mmol) in CD2Cl2 was placed
into an NMR tube equipped with a septum. Triflic acid (0.004 mL,
0.045 mmol) was added via syringe and the resulting solution analyzed
(C5Me5)Ru(η5-1,2,3,4,5,6-exo-hexamethylcyclohexadienyl) (7). A
suspension of [(C5Me5)Ru(η6-C6Me5H)]+BF4- (6, 0.165 g, 0.350 mmol)
in 6 mL of tetrahydrofuran was cooled to -78 °C using a dry ice/
acetone bath, and MeLi (1.4 M in diethyl ether, 0.75 mL, 1.050 mmol,
3.0 equiv) was added via syringe. The reaction was stirred at -78 °C
for several hours before gradually being warmed to room temperature.
The resulting yellow solution was then evaporated under low pressure,
and the residue was triturated with several portions of pentane. The
combined pentane extracts were filtered over Celite, and the yellow
filtrate was concentrated to a solid. After thorough drying in vacuo,
the yellow solid was dissolved in pentane and filtered through a plug
of alumina (5% H2O), giving a colorless filtrate. This filtrate was
concentrated under low pressure to give 0.058 g (42%) of white
crystalline material, which was used without further purification. IR
(CH2Cl2 cast, cm-1): 2959 (s), 2937 (s), 2902 (s), 2881 (s), 2852 (s),
1376 (m), 1265 (m), 1017(m), 740 (s). 1H NMR (400 MHz, CD2Cl2):
δ 2.02 (s, 3H, CH3), 1.94 (q, J ) 6.3 Hz, 1H, endo-H), 1.60 (s, 21H,
CH3 and C5Me5), 1.31 (s, 6H, CH3), 0.11 (d, J ) 6.3 Hz, 3H, exo-
CH3). 13C{1H} NMR (100 MHz, CD2Cl2): δ 88.1, 86.7, 86.5, 50.2,
39.9, 20.3, 20.2, 15.3, 14.4, 10.0. MS m/z (relative intensity): calculated
for C22H34102Ru (M+), 400.1704; found, 400.1687 (3.81); calculated
for C22H33102Ru (M - H), 399.1626; found, 399.1644 (6.55); calculated
for C21H31102Ru (M - CH3), 385.1469; found, 385.1464 (100.00).
1
by H and 13C{1H} NMR spectroscopy at room temperature and at
-80 °C. 1H NMR (400 MHz, CD2Cl2, 20 °C): δ 2.59 (br s, 1H, endo-
H), 2.37 (br s, 3H, CH3), 1.79 (br s, 12H, CH3), 1.77 (s, 15H, C5Me5),
1
0.33 (br s, 3H, exo-CH3), -5.73 (br s, 1H, Hag). H NMR (400 MHz,
CD2Cl2, -80 °C): δ 2.53 (br q, J ) 6.6 Hz, 1H, endo-H), 2.25 (s, 3H,
CH3), 1.71 (s, 12H, CH3), 1.67 (s, 15H, C5Me5), 0.22 (d, J ) 6.5 Hz,
3H, exo-CH3), -5.40 (br s, 1H, Hag). 13C{1H} NMR (100 MHz, CD2-
Cl2, 20 °C): δ 96.8, 9.8 (all other signals broadened into the baseline).
13C{1H} NMR (100 MHz, CD2Cl2, -80 °C): δ 98.6, 96.1, 95.6, 74.0,
51.2, 22.4, 19.8, 14.0, 12.8, 9.2 (triflate carbon not observed).
Qualitative spin saturation transfer experiments (400 MHz, CD2Cl2,
20 °C): irradiation of δ -5.73 (Hag) T suppression of the signal at
2.59 ppm (endo-H); irradiation of δ 0.33 (exo-CH3) T suppression of
the signal at 1.79 ppm (12H, CH3) and diminution of the signal at 2.37
ppm (3H, CH3).
(C5Me5)Ru(η5-1,2,3,4,5-pentamethyl-6-exo-CD3-cyclohexadien-
yl) (7-d3). A procedure similar to that described for complex 7 was
followed. A cold (-78 °C) suspension of (C5Me5)Ru(η6-C6Me5H)]+-
Addition of Water to 10. Excess distilled water (0.004 mL, 5.9
equiv) was added via microsyringe to the solution of [(C5Me5)Ru(η4-
1,2,3,4,5-exo-6-exo-hexamethylcyclohexa-1,3-diene)]+OTf- (10) pre-
pared above. The NMR tube was shaken for 1 min, after which time
the reaction was monitored by 1H NMR spectroscopy at 10-min
intervals. After 50 min, the conversion to [(C5Me5)Ru(η6-C6Me5H)]+-
OTf- (6) and methane (δ 0.20 ppm in CD2Cl2) was complete.
Protonation of (C5Me5)Ru(η5-1,2,3,4,5,6-exo-hexamethylcyclo-
hexadienyl) (7) with CF3SO3D (Prepared in Situ by Exchange with
Acetone-d6). In the drybox, a solution of (C5Me5)Ru(η5-1,2,3,4,5,6-
exo-hexamethylcyclohexadienyl) (7, 0.015 g, 0.038 mmol) in acetone-
d6 was placed into an NMR tube equipped with a rubber septum and
sealed. After removal of the solution from the drybox, triflic acid (0.004
mL, 0.045 mmol) was then added via syringe and the reaction monitored
spectroscopically. After 20 min at room temperature, 1H NMR showed
complete conversion of starting material to [(C5Me5)Ru(η4-1,2,3,4,5-
exo-6-exo-hexamethylcyclohexa-1,3-diene)]+OTf- (10) along with
traces of [(C5Me5)Ru(η6-C6Me5D)]+OTf- (6-d1). After 24 h at room
temperature, conversion to complex 6-d1 was complete, accompanied
by the formation of methane (δ 0.15 in acetone-d6) and methane-d1
(1:1:1 triplet at δ 0.13 in acetone-d6).
-
BF4 (6, 0.050 g, 0.106 mmol) in tetrahydrofuran was prepared, and
CD3Li (approximately 0.3 M in diethyl ether, 1.06 mL, 3.0 equiv) was
added by syringe. The flask was then warmed to room temperature
and the product isolated as described. Pale yellow crystals were
1
collected (0.015 g, 37%). H NMR (400 MHz, CD2Cl2): δ 2.02 (s,
3H, CH3), 1.93 (br s, 1H, endo-H), 1.60 (s, 21H, CH3 and C5Me5),
1.31 (s, 6H, CH3).
Protonation of Complex 5 with HBF4‚Et2O in Acetone-d6. In the
drybox, a solution of (C5H5)Ru(η5-1,2,3,4,5,6-endo-hexamethylcyclo-
hexadienyl) (5, 0.010 g, 0.030 mmol) in acetone-d6 was placed into an
NMR tube equipped with a rubber septum. Tetrafluoroboric acid
(diethyl ether complex, 85% in diethyl ether) (0.004 mL, 0.045 mmol)
was then added via microsyringe and the resulting solution analyzed
by 1H NMR spectroscopy. Clean conversion to [(C5H5)Ru(η6-C6Me6)]+-
-
BF4 (4) was observed within 10 min at room temperature.
[(C5H5)Ru(η4-1,2,3,4,5-exo-6-endo-hexamethylcyclohexa-1,3-di-
ene)]+BF4 (8). In the drybox, a solution of (C5H5)Ru(η5-1,2,3,4,5,6-
-
endo-hexamethylcyclohexadienyl) (5, 0.016 g, 0.049 mmol) in anhy-
drous CD2Cl2 was placed into an NMR tube equipped with a rubber
septum. Tetrafluoroboric acid (diethyl ether complex, 85%) was then
added (0.008 mL, 0.064 mmol) via microsyringe and the resulting
Protonation of (C5Me5)Ru(η5-1,2,3,4,5-pentamethyl-6-exo-CD3-
cyclohexadienyl) (7-d3) with CF3SO3H. A dichloromethane solution
of (C5Me5)Ru(η5-1,2,3,4,5-pentamethyl-6-exo-CD3-cyclohexadienyl) (7-
d3, 0.015 g, 0.037 mmol) was placed into an NMR tube and capped
1
1
yellow solution analyzed by H NMR spectroscopy. H NMR (400
MHz, CD2Cl2): δ 5.14 (s, 5H, C5H5), 2.82, (s, 3H, CH3), 2.50 (dq,
J ) 13.2, 6.6 Hz, 1H, exo-H), 2.17 (s, 6H, CH3), 1.67 (d, J ) 2.7 Hz,